Articles
Editorials
Should Ipilimumab Be the New “Standard” for Refractory MCC?
2024
Merkel Cell Carcinoma
Ipilimumab
Ipi/Nivo
In this editorial, we discuss the role of ipilimumab in anti-PD-1 refractory Merkel cell carcinoma. This topic was presented at the Third International Symposium for MCC in Houston, Texas on May 4th 2024.
No matching items
Perspectives on the Science
A Closer Look: Evaluating Mohs Surgery’s Role in the Treatment of Invasive Melanoma of the Head and Neck
2024
In this Perspectives on the Science piece, we reflect on the implications of the recently conducted multicenter study on the treatment of invasive head and neck melanoma using Mohs micrographic surgery.
No matching items